CPHL Citi Pharma Ltd.

Citi Pharma Ltd. (CPHL) financial ratios

Citi Pharma Ltd. earned a net margin of 5.6% in FY2026 against a five-year average of 6.2% (Pharmaceuticals median 9.4%). Return on equity was 7.3%, compared with a sector median of 21.7%. The current ratio stood at 1.25× and debt was 28.6% of equity. Cash took about 117 days to cycle through receivables, inventory and payables.

FY2026 vs the Pharmaceuticals median

Gross margin: 17.6%; Sector median 37.0%
Operating margin: 13.8%; Sector median 17.3%
Net margin: 5.6%; Sector median 9.4%
Return on equity (ROE): 7.3%; Sector median 21.7%
Return on assets (ROA): 4.3%; Sector median 11.7%
Current ratio: 1.25×; Sector median 1.79×
Debt to equity: 28.6%; Sector median 5.8%
Asset turnover: 0.77×; Sector median 1.26×
Dividend payout ratio: 101.2%; Sector median 32.8%

Median of the 14 companies in the sector with the figure for their latest fiscal year.

CPHL financial ratios (annual) (Rs mn)
Rs mn	FY2026 Jul 2025 – Jun 2026	FY2025 Jul 2024 – Jun 2025	FY2024 Jul 2023 – Jun 2024	FY2023 Jul 2022 – Jun 2023	FY2022 Jul 2021 – Jun 2022	FY2021 Jul 2020 – Jun 2021	FY2020 Jul 2019 – Jun 2020
Profitability
Gross margin	17.6%	15.3%	12.8%	12.2%	13.9%	13.5%	12.4%
EBITDA margin	15.2%	13.5%	10.8%	10.1%	10.9%	11.0%	8.7%
Operating margin	13.8%	12.2%	9.7%	9.4%	10.2%	9.9%	7.2%
Pre-tax margin	9.6%	10.3%	10.3%	7.7%	10.8%	8.6%	5.7%
Net margin	5.6%	6.8%	6.7%	5.3%	6.7%	6.1%	4.1%
Effective tax rate	41.2%	34.1%	34.8%	31.3%	38.4%	29.6%	29.2%
Returns
Return on equity (ROE)	7.3%	10.8%	15.1%	13.0%	14.4%	13.2%	—
Return on assets (ROA)	4.3%	6.0%	7.8%	7.3%	8.9%	7.8%	—
Return on invested capital (ROIC)	7.2%	10.5%	14.2%	11.5%	12.9%	11.7%	—
Liquidity
Current ratio	1.25×	1.30×	1.36×	1.48×	1.86×	2.45×	1.11×
Quick ratio	0.71×	0.76×	0.79×	0.89×	1.30×	2.03×	0.40×
Leverage
Debt to equity	28.6%	27.1%	25.8%	34.3%	20.0%	15.1%	48.8%
Debt to capital	22.2%	21.3%	20.5%	25.5%	16.7%	13.1%	32.8%
Debt to assets	17.0%	16.0%	12.8%	18.5%	11.6%	10.1%	19.3%
Assets to equity	1.69×	1.81×	1.94×	1.80×	1.61×	1.68×	—
Efficiency
Asset turnover	0.77×	0.88×	1.16×	1.37×	1.34×	1.29×	—
Receivable days days	101	73	60	48	35	23	—
Inventory days days	121	117	98	72	54	61	—
Payable days days	105	122	97	68	57	59	—
Cash conversion cycle days	117	68	61	53	31	25	—
Dividends
Dividend payout ratio	101.2%	83.2%	68.5%	0.0%	0.0%	0.0%	0.0%
Earnings retention rate	(0.01×)	0.17×	0.31×	1.00×	1.00×	1.00×	1.00×

Ratios as reported for each fiscal year; returns are on average equity / assets. Debt ratios are percentages; turnover in times; working-capital measures in days.

CPHL: frequently asked questions

What is CPHL's EPS?

Citi Pharma Ltd. reported basic earnings per share of Rs 3.46 for FY2026 (Jul 2025 – Jun 2026).

What is CPHL's P/E ratio?

At the closing price of Rs 61.66 on 16 Oct 2026, CPHL trades at a P/E of 17.8× based on EPS of Rs 3.46 (FY2026).

Does CPHL pay dividends?

Citi Pharma Ltd. did not declare a cash dividend for FY2026.

What was CPHL's revenue and profit in FY2026?

Citi Pharma Ltd. reported revenue of Rs 14.1 bn and profit attributable to shareholders of Rs 790.3 mn for FY2026 (Jul 2025 – Jun 2026).

What is CPHL's book value per share?

Citi Pharma Ltd.'s book value per share was Rs 47.42 at the end of FY2026. The shares trade at 1.30× book value.

Information only, not investment advice.